Erin Whalen
Nurse Practitioner · Peoria, ILNPI 1144795295
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,020 of the $34,288 with a category attached, or 81.7%. AstraZeneca accounts for 64.7% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $19,058, more than ten times the $1,507 reported in 2022. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $231.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$22K
- Daiichi Sankyo Inc.$10K
- AbbVie$230
- Novartis$223
- Seagen Inc.$122
- Johnson & Johnson$102
- plus $1K from 27 others
What the payments were for
- Consulting fees$1,7405%
- Speaking & faculty fees$28,02082%
- Travel & lodging$1,0723%
- Food & beverage$3,45610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 43 | $22,185 |
| Daiichi Sankyo Inc. | 16 | $10,376 |
| AbbVie | 8 | $230 |
| Novartis | 13 | $223 |
| Seagen Inc. | 7 | $122 |
| Johnson & Johnson | 5 | $102 |
| Merck | 6 | $98 |
| Eisai Inc. | 4 | $87 |
| GSK | 4 | $79 |
| Sanofi | 4 | $75 |
| Astellas Pharma US Inc | 4 | $67 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $57 |
| Lilly USA, LLC | 3 | $57 |
| Bristol Myers Squibb | 3 | $50 |
| Pfizer | 2 | $41 |
| Genentech USA, Inc. | 2 | $39 |
| Gilead(2 entities) | 2 | $34 |
| Bayer | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Organon | 1 | $30 |
| Incyte Corporation | 2 | $29 |
| Sobi, Inc | 1 | $29 |
| AVEO Pharmaceuticals, Inc. | 1 | $29 |
| CTI Biopharma Corp. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $19 |
| G1 Therapeutics, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Deciphera Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,288 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 32 | $4,838 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $1,772 |
| Morphine Sulfate ErMorphine Sulfate | 23 | $811 |
| Gabapentin | 15 | $448 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 25 | $425 |
| Morphine Sulfate | 13 | $419 |
| Prochlorperazine Maleate | 28 | $386 |
| Dexamethasone | 38 | $367 |
| Tramadol Hcl | 67 | $294 |
| Lorazepam | 54 | $237 |
| Oxycodone Hcl | 16 | $205 |
| Potassium Chloride | 19 | $197 |
| Triamcinolone Acetonide | 13 | $127 |
| Ondansetron Hcl | 16 | $112 |
| Levofloxacin | 23 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $57 | $2712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Peoria
- Cally SmithPeoria$26K
- Brynn CinnamonPeoria$17K
- Scott WilsonPeoria$16K
- Jennifer AliPeoria$11K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.